European Journal of Neurology

Article	Citations
Basal ganglia matter	260
Comparative analysis of dimethyl fumarate and teriflunomide in relapsing–remitting multiple sclerosis	133
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift	128
What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse?	101
Thank you to our peer reviewers in 2023	95
Possible benefit of second intravenous immunoglobulin course in Guillain−Barré syndrome patients with potentially poor prognosis	91
Benefits of influenza vaccine on stroke beyond preventing infection: Paradigm change or sheer bias?	90
Special Sessions	87
Machine‐learning‐derived heart and brain age are independently associated with cognition	84
Issue Information	83
European Journal of Neurology will flip to open access in January 2024	82
Issue Information	80
Spinal muscular atrophy: are small sensory fibres involved?	76
Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment	76
Blood pressure variability and functional outcome after decompressive hemicraniectomy in malignant middle cerebral artery infarction	76
Central nervous system crystal‐storing histiocytosis: A case report and literature review	61
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease	60
Mild cognitive impairment and early Alzheimer's disease eligibility for disease modification therapies in a tertiary centre for cognitive disorders: A simultaneous real‐word study on aducanumab and le	60
Lyme neuroborreliosis in Japan: Borrelia burgdorferi sensu lato as a cause of meningitis of previously undetermined etiology in hospitalized patients outside of the island of Hokkaido, 2010–202	56
The European Academy of Neurology NeuroCOVID‐19 Task Force: A lesson for the future	55
Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study	53
Enhancing multisensory rehabilitation of visual field defects with transcranial direct current stimulation: A randomized clinical trial	52
Issue Information	52
Dorsolateral pontine lesions produce distinct ocular motor abnormalities with anatomical correlations	52
Predictors of affective disturbances and cognitive impairment following small spontaneous supratentorial intracerebral hemorrhage	51

Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathies: A retrospective monocentric cohort study	50
Complement activation by IgM autoantibodies linked to immune‐mediated neuropathies depends on C2	50
Small fiber neuropathy associated with COVID‐19 infection and vaccination: A prospective case–control study	49
Cost‐utility analysis of a coadjutant telemedicine intervention for fall prevention in Parkinson's disease	46
Postural control in episodic ataxia type 2: no evidence for increased vestibular excitability	45
The presence and burden of cognitive issues: discordance between the perception of neurologists and people living with multiple sclerosis	43
Prognostic Value of Signal Abnormalities on Brain MRI in Post‐Anoxic Super‐Refractory Status Epilepticus: A Single‐Center Retrospective Study	42
Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation	41
Comparison of different surgical strategies for cervical dystonia: Evidence from Bayesian network analysis	41
A common marker of affect recognition dysfunction in the FTD spectrum of disorders	39
Assessment of the available evidence for the use of 7‐Tesla (T) magnetic resonance imaging (MRI) in neurological and musculoskeletal disorders, with comparison to 3‐T	39
Neglected outcomes of cerebrovascular disorders in neuromuscular diseases	39
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study	39
CORRIGENDUM	38
Diagnostic added value of interictal magnetic source imaging in presurgical evaluation of persons with epilepsy: A prospective blinded study	37
Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein–Barr virus	37
Lower serum uric acid to serum creatinine ratio as a predictor of poor functional outcome after mechanical thrombectomy in acute ischaemic stroke	37
Mechanical thrombectomy in young patients with large vessel occlusion‐related ischemic stroke: Data from the Italian Registry of Endovascular Treatment in Acute Stroke	36
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study	36
Clinical variables contributing to the identification of biologically defined subgroups within cognitively unimpaired and mild cognitive impairment individuals	35
Reply to “Serum neurofilament light chain and small fiber neuropathy: Every cloud has a silver lining” by D. Plantone and G. Primiano	35
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life	34
Blood pressure variability in acute stroke: Risk factors and association with functional outcomes at 1 month	34
Relationship between primary stroke center volume and time to endovascular thrombectomy in acute ischemic stroke	34
Effect of APOE ε4 genotype on amyloid‐β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment	33
Association of the COVID‐19 outbreak with acute stroke care in Switzerland	33
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients	33
Peripheral polyneuropathy in children and young adults with ataxia–telangiectasia	32
I spy with my little eye: The detection of changes in emotional faces and the influence of facial feedback in Parkinson disease	32
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis	32
Mirror therapy for unilateral neglect after stroke: A systematic review	32
Alterations of brain structural MRI are associated with outcome of surgical treatment in trigeminal neuralgia	32
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross‐sectional and longitudinal study	31
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report	31
Elevated serum anti‐Saccharomyces cerevisiae antibody accompanied by gut mycobiota dysbiosis as a biomarker of diagnosis in patients with de novo Parkinson disease	31
Different patterns of exosomal α‐synuclein between Parkinson's disease and probable rapid eye movement sleep behavior disorder	31
Response to Geroin et al.: Tapping into the mechanisms of abnormal functional postural control	31
	30
Thymectomy in myasthenia gravis: “The real world” experience beyond studies	30
Autoantibody levels as biomarkers of disease activity in the management of myasthenia gravis	30
The amnestic syndrome of posterior cerebral artery infarction	30
Long‐term consequences of subarachnoid haemorrhage: Is it time for new strategies?	30
Clinical value of Young Stroke Questionnaire	30
Sporadic Creutzfeldt–Jakob disease presenting as epilepsia partialis continua and non‐ictal nystagmus	29
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy	29
Undergraduate neurology training in the inpatient and outpatient setting: How do they differ?	29
Issue Information	29
Letter to the Editor: “Correlation between total homocysteine and cerebral small vessel disease: A Mendelian randomization study”	28
MAPT Q336H mutation: Intrafamilial phenotypic heterogeneity in a new Italian family	28
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis	28

From bedside to bench and back	28
Distinct disease trajectories in frontotemporal dementia–motor neuron disease and behavioural variant frontotemporal dementia: A longitudinal study	28
Circulating folate concentrations and the risk of mild cognitive impairment: A prospective study on the older Chinese population without folic acid fortification	27
Headaches and facial pain attributed to SARS‐CoV‐2 infection and vaccination: a systematic review	27
Issue Information	27
Iatrogenic cerebral amyloid angiopathy: An illustrative case of a newly introduced disease	27
Dysphagia in primary progressive aphasia: Clinical predictors and neuroanatomical basis	27
Comorbidity patterns in people with multiple sclerosis: A latent class analysis of the Australian Multiple Sclerosis Longitudinal Study	27
Toxoplasma gondii and multiple sclerosis: A systematic review and meta‐analysis	26
Discriminative value of different combinations of tests to detect unilateral neglect in patients with right hemisphere damage	26
Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis: An updated systematic review	26
The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis	25
Outcome of Guillain–Barré syndrome following intravenous immunoglobulin compared to natural course	25
Relapse‐associated worsening in a real‐life multiple sclerosis cohort: the role of age and pyramidal phenotype	25
Identification of UBA1 as the causative gene of an X‐linked non‐Kennedy spinal–bulbar muscular atrophy	25
Progressive conus medullaris lesions are suggestive of intravascular large B‐cell lymphoma	24
Prospective longitudinal study on prognostic factors of visual recovery and structural change after a first episode of optic neuritis	24
Ictal apnea: A prospective monocentric study in patients with epilepsy	24
Predicting functional outcome in patients with acute brainstem infarction using deep neuroimaging features	24
Focused Workshops	24
Neurological complications during the Omicron COVID‐19 wave in China: A cohort study	24
Neural correlates of self‐awareness of cognitive deficits in non‐demented patients with Parkinson's disease	24
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy	24
Ambient air pollution, covert cerebrovascular disease and cognition: results from the ISSYS study	23
Cross‐sectional study on patients' understanding and views of the informed consent procedure of a secondary stroke prevention trial	23
Issue Information	23
Small intracranial aneurysms of the anterior circulation: A negligible risk?	23
Association between striatal amyloid deposition and motor prognosis in Parkinson's disease	23
Myeloneuropathy induced by recreational nitrous oxide use with variable exposure levels	23
Issue Information	22
Determinants of adherence to post‐stroke/transient ischemic attack secondary prevention medications: A cohort study	22
Central nervous system tumours among users of vaginal oestradiol tablets: A nationwide population‐based study	22
Impact of diabetes mellitus on the respiratory function of amyotrophic lateral sclerosis patients	22
Cerebral venous sinus thrombosis associated with COVID‐19 vaccine‐induced thrombocytopenia: Improvement in mortality rate over time	22
Independent effects of amyloid and vascular markers on long‐term functional outcomes: An 8‐year longitudinal study of subcortical vascular cognitive impairment	22
Undiagnosed major risk factors in acute ischaemic stroke patients: frequency, profile, stroke mechanisms and outcome	22
Etiologic distribution of isolated trochlear palsy: Analysis of 1020 patients and literature review	22
Investigating paraneoplastic aquaporin‐4‐IgG‐seropositive neuromyelitis optica spectrum disorder through a data‐driven approach	21
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study	21
Analysis of co‐medication in people with dementia	21
Temporal trends and outcomes in acute ischaemic stroke patients with a current or historical diagnosis of cancer	21
	21
ePresentations	21
Topical Symposia	21
Ambulatory blood pressure and drug treatment for orthostatic hypotension as predictors of mortality in patients with multiple system atrophy	21
Sleep disorders and increased risk of dementia	21
Neuropathic pain ‐ Still a challenge to assess	21
Clinical evidence in ischemic stroke: Where we have gone so far and hopes for the future	21
Modulatory effects of vitamin D on IL ‐33/ ST2 immune axis in Guillain–Barré syndrome…quo vadis?	21
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome	21
How to approach a neurogenetics diagnosis in different European countries: The European Academy of Neurology Neurogenetics Panel survey	21
Minor stroke in large vessel occlusion: A matched analysis of patients from the German Stroke Registry–Endovascular Treatment (GSR‐ET) and patients from the Safe Implementation of Treatments in Stroke	21
Seizures—the second most frequent neurological emergency	21
Did Martin Luther suffer from vestibular migraine?	21
Lessons from the past to understand the future	21
Symposia	20
Association of HMOX‐1 with sporadic Alzheimer’s disease in southern Han Chinese	20
Late‐breaking Abstracts	20
TheCYP24A1gene variant rs2762943 is associated with low serum 1,25‐dihydroxyvitamin D levels in multiple sclerosis patients	20
Reply to the letter from Gazulla et al.	20
Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures	20
Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients	20
Issue Information	20
Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta‐analysis of randomized controlled trials	20
	20
Association of cholesterol level with dopamine loss and motor deficits in Parkinson disease: A cross‐sectional study	20
Adult onset epilepsy incidence in Finland over 34 years: A nationwide registry study	20
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective	20
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study	20
The decline in stroke hospitalization due to COVID‐19 is unrelated to COVID‐19 intensity	19
Guillain–Barré syndrome following influenza vaccination: A 15‐year nationwide population‐based case–control study	19
Brain magnetic resonance imaging lesion load at diagnosis, severity at onset and outcomes in Susac syndrome: A prospective cohort study	19
Clinical correlates of fear of falling in progressive supranuclear palsy and multiple system atrophy	19
Real‐world smartphone data can trace the behavioural impact of epilepsy: A case study	19
Large disparities in 28‐day case fatality by stroke subtype: data from a French stroke registry between 2008 and 2017	19
History of cerebrovascular disease but not dementia increases the risk for secondary vascular events during SARS‐CoV‐2 infection with presumed Omicron variant: a retrospective observational	19
Antibody response elicited by the SARS‐CoV‐2 vaccine booster in patients with multiple sclerosis: Who gains from it?	19
Non‐demyelinating disorders mimicking and misdiagnosed asNMOSD:a literature review	19
Quantitative magnetic resonance imaging of the brachial plexus shows specific changes in nerve architecture in chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy and motor	19
A strategic neurological research agenda for Europe: Towards clinically relevant and patient‐centred neurological research priorities	19

Movement disorders in valine métabolism diseases caused by HIBCH and ECHS1 deficiencies	18
Risk factors for the progression of motoric cognitive risk syndrome to dementia: Retrospective cohort analysis of two populations	18
Melatonin's role in managing nocturia in Parkinson disease: A critical examination of recent studies	18
Issue Information	18
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study	18
Predictors of malnutrition risk in neurodegenerative diseases: The role of swallowing function	18
Prevalence and clinical profiles of anti‐myelin‐associated glycoprotein neuropathy in Japan: A nationwide survey study of 133 patients	18
Efficacy and safety of botulinum toxin for treating sialorrhea: A systematic review and meta‐analysis	18
Prevalence of acute dizziness and vertigo in cortical stroke	18
Chronic inflammatory demyelinating polyradiculoneuropathy‐associated tremor: Phenotype and pathogenesis	18
Tumefactive multiple sclerosis or inflammatory demyelinating disease with large lesions?	18
Movement disorders following mechanical thrombectomy resulting in ischemic lesions of the basal ganglia: An emerging clinical entity	18
Issue Information	17
Sporadic Creutzfeldt–Jakob disease with extremely long 14‐year survival period	17
Predictors for the development of neurological immune‐related adverse events of immune checkpoint inhibitors and impact on mortality	17
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosis	17
Characteristics and temporal evolution of asymptomatic diffusion‐weighted imaging lesions in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (<	17
Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: Identifying relevant outcome factors	17
COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition	17
Association between serum secretory phospholipase A2 and risk of ischaemic stroke	17
Reply to the letter: Headaches during/after SARS‐CoV‐2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and M	17
Optical coherence tomography assessment of disease activity in cryopyrin‐associated periodic syndrome	17
Global trends in symptomatic medication use against dementia in 66 countries/regions from 2008 to 2018	17
Functional connectivity in Lewy body disease with visual hallucinations	17
Sex differences in clinical characteristics of migraine and its burden: a population‐based study	17
Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis	17
Anti‐CD20 therapy for multiple sclerosis‐associated uveitis: A case series	17
Reduction in cerebral oxygen metabolism in subcortical regions may be a biomarker of cognitive decline in people living with human immunodeficiency virus	17
Severity of in vivo corticospinal tract degeneration is associated with survival in amyotrophic lateral sclerosis: a longitudinal, multicohort study	17
Modifiable vascular risk factors in patients with cerebral and spinal cavernous malformations: a complete 10‐year follow‐up study	17
Serum neurofilament light chain cut‐off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis	17
Prevalence of disability improvement in relapsing–remitting multiple sclerosis patients treated with cladribine tablets	17
Proteinuria is a key to suspect autoimmune nodopathies	17
The effect of influenza vaccination on the rate of dementia amongst older adults	17
Association of peripapillary hyper‐reflective ovoid masslike structures and disease duration in primary progressive multiple sclerosis	17
Electrophysiological, histopathological, and biochemical evaluation of the protective effect of probiotic supplementation against pentylenetetrazole‐induced seizures in rats	17
Factors affecting the topography of nitrous oxide‐induced neurological complications	17
The real‐world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody‐associated disease criteria in a Latin American cohort	16
Improved diagnostic performance of high‐sensitivity cardiac troponins in muscle dystrophies using comprehensive definition criteria for cardiac involvement: A longitudinal study on 35 patients	16
Immune triggers preceding neuralgic amyotrophy	16
Serum liver enzymes and risk of stroke: Systematic review with meta‐analyses and Mendelian randomization studies	16
Endovascular therapy versus no endovascular therapy in patients receiving best medical management for acute isolated occlusion of the posterior cerebral artery: A systematic review andmeta‐analys	16
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment	16
Novel cognitive screening tests to address new clinical priorities and cultural diversity	16
Factors associated with the severity of COVID‐19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID‐19 Registry	16
Incidence rate and prevalence of pediatric‐onset multiple sclerosis in Sweden: A population‐based register study	16
Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease	16
Genetic profiles of multiple system atrophy revealed by exome sequencing, long‐read sequencing and spinocerebellar ataxia repeat expansion analysis	16
Risk of aspiration pneumonia and hospital mortality in Parkinson disease: A systematic review and meta‐analysis	16
Neuromuscular ultrasound in combination with nerve conduction studies helps identify inflammatory motor neuropathies from lower motor neuron syndromes	16
Computed tomography angiography in the diagnosis of brain death: Implementation and results in Germany	16
Relapsing–remitting and secondary‐progressive multiple sclerosis patients differ in decoding others' emotions by their eyes	16
Anti‐neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia—a case report and review of the literature	16
Comparative features and outcomes of major neurological complications of COVID‐19	16
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage	16
Cholinergic dysfunction in isolated rapid eye movement sleep behaviour disorder links to impending phenoconversion	16
Relationship between growth and ambulation loss in Duchenne muscular dystrophy boys on steroids	16
Elevated serum circulating cell‐free mitochondrial DNA in amyotrophic lateral sclerosis	16
Behavioral therapy in migraine: Expanding the therapeutic arsenal	16
Risk of disease relapse, safety and tolerability of SARS‐CoV‐2 vaccination in patients with chronic inflammatory neuropathies	16
Validation of a “subjective motoric cognitive risk syndrome” screening tool for motoric cognitive risk syndrome—A prospective cohort study	16
Benign recurrent lymphocytic meningitis (Mollaret's meningitis) in Denmark: a nationwide cohort study	16
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐sectional analysis from the MS‐STAT2 randomized controlled trial	16
A roadmap toward promoting and improving brain health in Europe and closing the awareness and funding gap	15
Novel PKD1 Mutation (c.G10086T) Drives High Intracranial Aneurysm Risk in Autosomal Dominant Polycystic Kidney Disease	15
Insomnia disorder: clinical and research challenges for the 21st century	15
	15
Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder	15
Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal	15
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms	15
Circle of Willis variants and their association with outcome in patients with middle cerebral artery‐M1‐occlusion stroke	15
Prevalence and clinical aspects of obstructive sleep apnea in Parkinson disease: A meta‐analysis	15
RE‐START: Exploring the effectiveness of anti‐calcitonin gene‐related peptide resumption after discontinuation in migraine	15
Parkinson's disease genome‐wide association study‐linked PARK16 variant is associated with a lower risk of cognitive impairment: A 4‐year observational study	15
Association of major blood lipids with post‐stroke dementia: A community‐based cohort study	15
The COVID‐19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics	15
Diagnostic accuracy of cerebrospinal fluid biomarkers for the differential diagnosis of sporadic Creutzfeldt–Jakob disease: a (network) meta‐analysis	15
Sensitized rotatory motion perception and increased susceptibility to motion sickness in vestibular migraine: A cross‐sectional study	15
The location of intraparenchymal bleeding determines functional outcome after spontaneous subarachnoid hemorrhage	15
Risk of poststroke epilepsy after reperfusion therapies: A national cohort study	15
Response to Letter to the Editor: Clarifying Diagnostic Criteria and the Role of Serum Neurofilament Light Chain in Immune‐Mediated Neuropathies	15
The history of the European Neurological Society (1986–2014)—10 years later	15
Prevalence and determinants of pain in chronic inflammatory demyelinating polyneuropathy: Results from the German INHIBIT registry	15
Plasma neurofilament light chain levels predict improvement in late phase after stroke	15
Functional connectivity and metabolic brain alterations in sleepwalkers	15
COVID‐19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark	15
Immunity and Gilles de la Tourette syndrome: A systematic review and meta‐analysis of evidence for immune implications in Tourette syndrome	15
ePosters	14
Caveolinopathy: Clinical, histological, and muscle imaging features and follow‐up in a multicenter retrospective cohort	14
Characterization and quantification of alcohol‐related polyneuropathy by magnetic resonance neurography	14
Pulmonary arteriovenous malformations in patients with previous brain abscess: a cross‐sectional population‐based study	14
Increased risk of Parkinson's disease amongst patients with age‐related macular degeneration and visual disability: A nationwide cohort study	14
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?	14
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis	14
Correlations between serotonin impairments and clinical indices in multiple system atrophy	14